Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary
Ryoko Takahashi(The University of Tokyo), Tadashi Kimura(Sakai Municipal Hospital)
Cited by 34